RMD
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read moreDetails
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial...
Read moreDetails
ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read moreDetails
Here’s Why ResMed (RMD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why...
Read moreDetails
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief...
Read moreDetails
ResMed Gains 37.8% in a Year: What’s Driving the Stock?
RMD's shares gain on the back of robust mask and device sales growth. However, the unfavorable macroeconomic scenario is concerning.
Read moreDetails
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?
ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for...
Read moreDetails
Here’s Why ResMed (RMD) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top...
Read moreDetails